-
-
-
-
-
-
-
4D Molecular Therapeutics, Inc. (FDMT) Tops Q3 EPS by 37c
-
-
-
-
-
-
-
4D Molecular Therapeutics Inc. (FDMT) Provides 4D-310 Program Update; Reports Q2
-
-
-
-
-
-
-
4D Molecular Therapeutics Reports Full Year 2021 Financial Results and Operational Highlights
-
-
-
-
-
-
-
4D Molecular Therapeutics Reports Financial Results for the Year Ended December 31, 2020 and Provides Operational Highlights
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

